Stockreport

Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment

Clene Inc.  (CLNN) 
PDF SALT LAKE CITY, March 12, 2025 (GLOBE NEWSWIRE) -- Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company [Read more]